Quest Diagnostics
Recent developments reported by Quest Diagnostics
Published in Patient Care Law Weekly, May 13th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Quest Diagnostics.
Report 1: Quest Diagnostics Incorporated (DGX) announced that for the fourth quarter income from continuing operations was $151 million, or $0.77 per diluted share compared to $149 million, or $0.73 per diluted share for the prior year.
Fourth quarter revenues from continuing operations grew 8.5% over the prior year level to $1.5 billion. The acquisitions of LabOne, which was completed on November 1, 2005, and Focus Diagnostics, which was completed on July 1,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
More Articles from Patient Care Law Weekly
- Aging
NIC Commissions First Compendium on Long-Term Care Financing - Aging
President & CEO, American Association of Homes and Services for the Aging comments on Report on Nursing Home Oversight - Arrhythmia
Arrhythmia Detection and Alarm Consortium Established - Behavioral Science
National Patient Safety Foundation Partners with Behavioral Science Technology, Inc. - Bioscience
Napo Pharmaceuticals, Inc. announces board changes - BlueCross BlueShield of South Carolina
Faulds Retires, Pankau and Others Promoted at BlueCross BlueShield of South Carolina - More from this issue of Patient Care Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
